Free tool
Drug Trial Radar
Last checked: Nov 20, 2026Latest source record: Nov 19, 2026 (registry update on this page)ClinicalTrials.gov last updated: Nov 20, 2026Methods & limitations
Filters
Filters are saved in the page address, so a filtered view can be bookmarked or shared.
Matching drug trials
55
Recruiting, any sponsor type, condition "prevention of pregnancy"
By trial status
The same filters, counted in each status. Pick one to switch.
- Completed478
55 trials
Showing 1 to 25, recently updated first.
Singulera Therapeutics Inc.Industry
NCT06552169 · 34 participants (planned) · Start Jun 13, 2025 · Primary completion Dec 2027
Drug: Arm 1: SOC (mTOR + CNI); Arm 2A: TRACT/MONO mTOR and 1 more · For: Kidney Transplantation
Sites: Phoenix, Arizona; Chicago, Illinois; Rochester, Minnesota · 7 sites in all
- Prevention of Nephrotoxin-Induced Acute Kidney Injury Using CilastatinPivotal-lookingRecruiting
Matthew JamesAcademic, hospital or other
NCT06886464 · 698 participants (planned) · Start Jul 16, 2025 · Primary completion Dec 31, 2027
Drug: Cilastatin Sodium; Placebo-Saline · For: Acute Kidney Injury
Sites: Calgary, Canada; Edmonton, Canada
- VTE Prevention With Rivaroxaban in Genitourinary Cancer Patients Receiving Systemic TherapyPivotal-lookingRecruiting
Ottawa Hospital Research InstituteAcademic, hospital or other
NCT05920343 · 120 participants (planned) · Start Nov 4, 2024 · Primary completion Jun 2028
Drug: Rivaroxaban 10 MG · For: Venous Thromboembolism; Urologic Cancer
Sites: Hamilton, Canada; London, Canada; Ottawa, Canada
- The GranStone TrialPivotal-lookingRecruiting
Martin Blomberg JensenAcademic, hospital or other
NCT07828002 · 100 participants (planned) · Start Oct 20, 2026 · Primary completion Mar 2029
Drug: empagliflozin (Jardiance) 25 mg; Losartan 100 mg · For: Paraffinoma; Granuloma, Foreign-Body
Sites: Herlev, Denmark
- Use Misoprostol to Optimize Prevention of Cervical CancerPivotal-lookingRecruiting
University of Alabama at BirminghamAcademic, hospital or other
NCT06669533 · 840 participants (planned) · Start Feb 25, 2025 · Primary completion Nov 4, 2027
Drug: Placebo; Misoprostol · For: Cervical Cancers
Sites: Yaoundé, Cameroon
Instituto de Investigación Biomédica de SalamancaAcademic, hospital or other
NCT07348484 · 300 participants (planned) · Start Apr 1, 2026 · Primary completion Apr 2028
Drug: Empagliflozin · For: Chronic Kidney Disease
Sites: Salamanca, Spain
- Tranexamic Acid to Prevent Heavy Bleeding After Childbirth in Women at Higher RiskPivotal-lookingRecruiting
London School of Hygiene and Tropical MedicineAcademic, hospital or other
NCT05562609 · 40,000 participants (planned) · Start Apr 22, 2024 · Primary completion Sep 2027
Drug: Tranexamic acid · For: Postpartum Hemorrhage
Sites: Mbeya, Tanzania
- Focal Mass Drug Administration for the Prevention of Malaria in PregnancyPivotal-lookingRecruiting
University of North Carolina, Chapel HillAcademic, hospital or other
NCT07021430 · 300 participants (planned) · Start Apr 22, 2026 · Primary completion Sep 2028
Drug: Dihydroartemisinin Piperaquine · For: Malaria Prevention
Sites: Kasese, Uganda
- Inorganic Nitrate (NaNO3) Prevention of Contrast-Associated Acute Kidney InjuryPivotal-lookingRecruiting
University of MichiganAcademic, hospital or other
NCT07016074 · 100 participants (planned) · Start Jun 30, 2025 · Primary completion Nov 30, 2026
Drug: Sodium Nitrate; Placebo · For: Kidney Injury, Acute
Sites: Ann Arbor, Michigan
- Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIALPivotal-lookingRecruiting
Ohio State UniversityAcademic, hospital or other
NCT06468202 · 10,742 participants (planned) · Start Oct 18, 2024 · Primary completion Jan 1, 2029
Drug: Aspirin 81 mg; Aspirin 162 mg · For: Hypertensive Disorders of Pregnancy; Preeclampsia; Gestational Hypertension
Sites: Birmingham, Alabama; Los Angeles, California; San Francisco, California · 20 sites in all
- Trial to Assess the Efficacy of EMPAgliflozin and Personalized Dietary Counseling for Kidney STONE PreventionPivotal-lookingRecruiting
Insel Gruppe AG, University Hospital BernAcademic, hospital or other
NCT06653738 · 400 participants (planned) · Start Jul 2, 2026 · Primary completion Sep 2030
Drug: Empagliflozin 10 MG; Placebo · For: Kidney Stone; Nephrolithiasis; Dietary Exposure
Sites: Amiens, France; Paris, France; Berlin, Germany · 21 sites in all
- Prevention of Postpartum Hemorrhage With Tranexamic AcidPivotal-lookingRecruiting
Inova Health Care ServicesAcademic, hospital or other
NCT05370820 · 120 participants (planned) · Start Dec 28, 2022 · Primary completion Oct 1, 2027
Drug: Tranexamic acid; Tranexamic acid and 1 more · For: Post Partum Hemorrhage
Sites: Washington D.C., District of Columbia; Falls Church, Virginia
- Prevent Cardiac Surgery Associated AKI TrialPivotal-lookingRecruiting
George Washington UniversityAcademic, hospital or other
NCT06620523 · 242 participants (planned) · Start Jul 18, 2024 · Primary completion Jun 17, 2027
Drug: CoQ10 1200 mg orally with Glutathione 1000 mg orally; Group B: Placebo CoQ10 orally and Placebo Glutathione orally · For: Renal Failure; Coronary Artery Disease; Surgery and 1 more
Sites: Washington D.C., District of Columbia
- Evaluate the Efficacy and Safety of U101 Oral Capsules in the Prevention of Uncomplicated rUTIs in WomenPivotal-lookingRecruiting
TCM Biotech International Corp.Industry
NCT07184827 · 348 participants (planned) · Start Oct 14, 2020 · Primary completion Jun 30, 2028
Drug: U101 · For: Recurrent Urinary Tract Infections in Women
Sites: Chiayi City, Taiwan; Douliu, Taiwan; Kaohsiung City, Taiwan · 18 sites in all
- Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational DiabetesPivotal-lookingRecruiting
Universitaire Ziekenhuizen KU LeuvenAcademic, hospital or other
NCT05569772 · 252 participants (planned) · Start Sep 14, 2023 · Primary completion Mar 2030
Drug: Semaglutide Pen Injector; Semaglutide placebo · For: Glucose Intolerance After a Recent History of Gestational Diabetes
Sites: Aalst, Belgium; Antwerp, Belgium; Bruges, Belgium · 13 sites in all
- Prophylactic Use of Tamsulosin in the Prevention of Post-operative Urinary Retention in Men After Rectum ResectionPivotal-lookingRecruiting
CHU de Quebec-Universite LavalAcademic, hospital or other
NCT05941806 · 220 participants (planned) · Start Nov 10, 2023 · Primary completion Jul 30, 2027
Drug: pr Sandoz Tamsulosin; Glucose · For: Urinary Retention; Colorectal Surgery; Rectal Resection and 2 more
Sites: Québec, Canada
- Xylitol and the Prevention of Periodontal Disease and Preterm Birth TrialPivotal-lookingRecruiting
University of WashingtonAcademic, hospital or other
NCT07424846 · 6,000 participants (planned) · Start Mar 26, 2026 · Primary completion Sep 30, 2030
Drug: Xylitol Chewing gum · For: Preterm Birth; Low Birthweight Neonate; Periodontitis and 2 more
Sites: Lilongwe, Malawi
- Efficacy and Safety of Nefecon on Prevention of Relapse of IgA NephropathyPivotal-lookingRecruiting
Nanfang Hospital, Southern Medical UniversityAcademic, hospital or other
NCT07604311 · 288 participants (planned) · Start Jun 23, 2026 · Primary completion Dec 1, 2028
Drug: NEFECON; Placebo · For: IgA Nephropathy (IgAN)
Sites: Guangzhou, China
Emory UniversityAcademic, hospital or other
NCT06492070 · 70 participants (planned) · Start Aug 1, 2024 · Primary completion Dec 31, 2026
Drug: Cilostazol; Paclitaxel · For: Cervical Carcinoma; Fallopian Tube Carcinoma; Malignant Solid Neoplasm and 4 more
Sites: Atlanta, Georgia · 3 sites in all
- Methenamine Hippurate Following Intradetrusor OnabotulinumtoxinA InjectionPivotal-lookingRecruiting
Women and Infants Hospital of Rhode IslandAcademic, hospital or other
NCT06953271 · 164 participants (planned) · Start Aug 1, 2025 · Primary completion Jan 30, 2027
Drug: Methenamine Hippurate; Typically prescribed oral antibiotic prophylaxis · For: Overactive Bladder (OAB); Urinary Tract Infection (Diagnosis)
Sites: Providence, Rhode Island
- Progesterone PreeclampsiaPivotal-lookingRecruiting
Medical University of South CarolinaAcademic, hospital or other
NCT07448597 · 642 participants (planned) · Start Aug 13, 2026 · Primary completion Aug 1, 2028
Drug: Progesterone supplementation · For: Preeclampsia; Hypertensive Disorder of Pregnancy
Sites: Charleston, South Carolina
Ohio State University Comprehensive Cancer CenterAcademic, hospital or other
NCT06741072 · 55 participants (planned) · Start Jun 28, 2026 · Primary completion Jul 31, 2027
Drug: Dulbecco''s Phosphate-Buffered Saline; Peptide Vaccine and 1 more · For: Chronic Kidney Disease, Stage 4; Chronic Kidney Disease, Stage 5; EBV-Related Lymphoproliferative Disorder and 2 more
Sites: Columbus, Ohio
- Topical Tranexamic Acid to Reduce Blood Loss During Cesarean DeliveryPivotal-lookingRecruiting
Wolfson Medical CenterGovernment (non-federal)
NCT07362992 · 112 participants (planned) · Start Jul 1, 2026 · Primary completion Dec 1, 2028
Drug: Tranexamic Acid (Topical) · For: Cesarean Delivery; Postpartum Hemorrhage (PPH); Intraoperative Blood Loss and 1 more
Sites: Holon, Israel; Kfar Saba, Israel; Petah Tikva, Israel · 4 sites in all
- LSALT Peptide for Prevention or Attenuation of Acute Kidney Injury (AKI) in Patients Undergoing On-Pump Cardiac SurgeryPivotal-lookingRecruiting
Arch Biopartners Inc.Industry
NCT05879432 · 240 participants (planned) · Start Mar 8, 2024 · Primary completion Mar 2027
Drug: LSALT Peptide; Placebo · For: Acute Kidney Injury; Cardiac Surgery
Sites: Calgary, Canada; New Westminster, Canada; Toronto, Canada · 9 sites in all
- Evaluation of Antimicrobial Prophylaxis to Prevent Syphilis in Pregnancy in Patients at Risk in Rio de Janeiro, BrazilPivotal-lookingRecruiting
University of California, Los AngelesAcademic, hospital or other
NCT07189208 · 500 participants (planned) · Start Sep 24, 2025 · Primary completion Dec 1, 2029
Drug: Benzathine penicillin 2.4 million units · For: Congenital Syphilis
Sites: Duque de Caxias, Brazil; Rio de Janeiro, Brazil · 4 sites in all
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.